BlackRock Investment Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

BlackRock Investment Management’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-84,768	Closed	-$553K	–	4173
2016 Q1	$553K	Buy	84,768 +1,597	+2%	+$10.3K	﹤0.01%	2851
2015 Q4	$675K	Buy	83,171 +224	+0.3%	+$1.67K	﹤0.01%	2856
2015 Q3	$608K	Buy	82,947 +1,601	+2%	+$16.3K	﹤0.01%	2934
2015 Q2	$834K	Buy	81,346 +80,247	+7,302%	+$887K	﹤0.01%	2901
2015 Q1	$10K	Hold	1,099	–	–	﹤0.01%	3660
2014 Q4	$8K	Buy	+1,099	New	+$6.29K	﹤0.01%	3775

Other funds holding FOMX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

BlackRock Investment Management's FOMX Position: Q2 2016 in Review

BlackRock Investment Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q2 2016, closing a stake of 84,768 shares — an estimated $553K sold.

BlackRock Investment Management first reported a position in FOMX in Q4 2014 and held it in 6 quarters. The position peaked at $834K in Q2 2015. 56 funds tracked by Wall St. Rank hold FOMX as of Q2 2016.

BlackRock Investment Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q2 2016 after selling out during the quarter.
BlackRock Investment Management sold 84,768 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q2 2016, an estimated $553K.
BlackRock Investment Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2014 and held it in 6 quarters.
BlackRock Investment Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $834K in Q2 2015.
56 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.